Skip to main content
Premium Trial:

Request an Annual Quote

On News of Illumina Bid, Solexa Shares Climb 29 Percent as Illumina's Dive 13 Percent

NEW YORK (GenomeWeb News) — Shares in Solexa were up 29 percent and shares in Illumina were down 13 percent in midday trading after Illumina said this morning it plans to buy Solexa for roughly $600 million in stocks.
 
Solexa was trading up $2.83 a share at $12.51 while Illumina was trading down $5.75 at $38.28.
 
In its third -quarter earnings report, also disclosed today, Solexa posted a net loss of $9.9 million and a 33-percent drop in revenuue.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.